Recombinant multi-species ANGPTL4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ANGPTL4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a glycosylated, secreted protein containing a C-terminal fibrinogen domain. The encoded protein is induced by peroxisome proliferation activators and functions as a serum hormone that regulates glucose homeostasis, lipid metabolism, and insulin sensitivity. This protein can also act as an apoptosis survival factor for vascular endothelial cells and can prevent metastasis by inhibiting vascular growth and tumor cell invasion. The C-terminal domain may be proteolytically-cleaved from the full-length secreted protein. Decreased expression of this gene has been associated with type 2 diabetes. Alternative splicing results in multiple transcript variants. This gene was previously referred to as ANGPTL2 but has been renamed ANGPTL4. [provided by RefSeq, Sep 2013]
The Alternative Names of target: ANGPTL4,ARP4,Angiopoietin-like protein 4,Angiopoietin-related protein 4,Angptl4,Arp4,Bk89,FIAF,Fiaf,HARP,HFARP,Hepatic fibrinogen/angiopoietin-related protein (HFARP),Hfarp,NL2,Ng27,PGAR,Pgar,Pgarg,Pp1158,TGQTL,UNQ171,pp1158

Target products collectionGo to ANGPTL4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T98635-Ag-1/ GM-Tg-hg-T98635-Ag-2 Human ANGPTL4 protein Human
GM-Tg-rg-T98635-Ag-1/ GM-Tg-rg-T98635-Ag-2 Rat ANGPTL4 protein Rat
GM-Tg-mg-T98635-Ag-1/ GM-Tg-mg-T98635-Ag-2 Mouse ANGPTL4 protein Mouse
GM-Tg-cynog-T98635-Ag-1/ GM-Tg-cynog-T98635-Ag-2 Cynomolgus/Rhesus macaque ANGPTL4 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T98635-Ag-1/ GM-Tg-felg-T98635-Ag-2 Feline ANGPTL4 protein Feline
GM-Tg-cang-T98635-Ag-1/ GM-Tg-cang-T98635-Ag-2 Canine ANGPTL4 protein Canine
GM-Tg-bovg-T98635-Ag-1/ GM-Tg-bovg-T98635-Ag-2 Bovine ANGPTL4 protein Bovine
GM-Tg-equg-T98635-Ag-1/ GM-Tg-equg-T98635-Ag-2 Equine ANGPTL4 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T98635-Ag-1/ GM-Tg-hg-T98635-Ag-2; GM-Tg-rg-T98635-Ag-1/ GM-Tg-rg-T98635-Ag-2;
GM-Tg-mg-T98635-Ag-1/ GM-Tg-mg-T98635-Ag-2; GM-Tg-cynog-T98635-Ag-1/ GM-Tg-cynog-T98635-Ag-2;
GM-Tg-felg-T98635-Ag-1/ GM-Tg-felg-T98635-Ag-2; GM-Tg-cang-T98635-Ag-1/ GM-Tg-cang-T98635-Ag-2;
GM-Tg-bovg-T98635-Ag-1/ GM-Tg-bovg-T98635-Ag-2; GM-Tg-equg-T98635-Ag-1/ GM-Tg-equg-T98635-Ag-2
Products Name ANGPTL4 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name ANGPTL4
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ANGPTL4 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.